Search alternatives:
ppm decrease » a decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
auc decrease » a decrease (Expand Search), a decreased (Expand Search), c decreased (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
5 nn » 5 non (Expand Search), 59 nn (Expand Search), 5 nm (Expand Search)
Showing 1 - 20 results of 72,980 for search '(( 5 ((ppm decrease) OR (_ decrease)) ) OR ((( 5 nn decrease ) OR ( _ auc decrease ))))', query time: 0.56s Refine Results
  1. 1
    Sodium taurocholate decreased higher order oligomerization.

    Sodium taurocholate decreased higher order oligomerization. by Eunhee Lee (804130)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  2. 2
    Prediction of hyperemic coronary flow decrease.

    Prediction of hyperemic coronary flow decrease. by Eisuke Usui (12111855)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 3
    Fig 5 -

    Fig 5 - by Dennis Ochola (11626912)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 4
    D-4F and L-5F decrease hepatic mRNA level of genes involved in gluconeogenesis.

    D-4F and L-5F decrease hepatic mRNA level of genes involved in gluconeogenesis. by Kristine C. McGrath (8269155)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  5. 5
    D-4F and L-5F decrease hepatic mRNA level of genes involved in inflammation.

    D-4F and L-5F decrease hepatic mRNA level of genes involved in inflammation. by Kristine C. McGrath (8269155)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  6. 6
    D-4F and L-5F decrease hepatic mRNA levels of genes involved in lipogenesis.

    D-4F and L-5F decrease hepatic mRNA levels of genes involved in lipogenesis. by Kristine C. McGrath (8269155)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  7. 7
    D-4F and L-5F decrease hepatic mRNA levels of monocyte-macrophage markers.

    D-4F and L-5F decrease hepatic mRNA levels of monocyte-macrophage markers. by Kristine C. McGrath (8269155)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  8. 8
    AUC raw data.

    AUC raw data. by Jack B. Maguire (5123183)

    Published 2021
    Save to List
    Saved in:
  9. 9
    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the Treatment of Ulcerative Colitis

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 10
    D-4F and L-5F improves blood glucose.

    D-4F and L-5F improves blood glucose. by Kristine C. McGrath (8269155)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  11. 11
    D-4F and L-5F improves insulin sensitivity.

    D-4F and L-5F improves insulin sensitivity. by Kristine C. McGrath (8269155)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  12. 12
    D-4F and L-5F attenuate hepatic triglyceride accumulation.

    D-4F and L-5F attenuate hepatic triglyceride accumulation. by Kristine C. McGrath (8269155)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  13. 13
    Antibody-dependent cellular cytotoxicity (ADCC) activity reported as AUC.

    Antibody-dependent cellular cytotoxicity (ADCC) activity reported as AUC. by LaTonya D. Williams (3140490)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 14
    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography

    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  15. 15
    Population characteristics.

    Population characteristics. by O. Stivalet (6890189)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  16. 16
    Flow chart.

    Flow chart. by O. Stivalet (6890189)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  17. 17
    Prevalence and anatomic level of stenosis ≥ 50% in either limb.

    Prevalence and anatomic level of stenosis ≥ 50% in either limb. by O. Stivalet (6890189)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  18. 18
    Exercise test characteristics for identifying stenosis ≥ 50% in any limb among the 60 limbs with normal ABIs (> 0.91).

    Exercise test characteristics for identifying stenosis ≥ 50% in any limb among the 60 limbs with normal ABIs (> 0.91). by O. Stivalet (6890189)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  19. 19
    Test characteristics for identifying stenosis ≥ 50% in any limb from aorta till popliteal artery in the overall population (<i>n = 126 limbs</i>).

    Test characteristics for identifying stenosis ≥ 50% in any limb from aorta till popliteal artery in the overall population (<i>n = 126 limbs</i>). by O. Stivalet (6890189)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  20. 20
    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography - Fig 2

    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography - Fig 2 by O. Stivalet (6890189)

    Published 2019
    Subjects:
    Save to List
    Saved in:

Search Tools: